Investors View Helen Of Troy (HELE) as Flu Season Play
Tweet Send to a FriendGet Alerts HELE Hot Sheet
Price: $38.92 +0.18%
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade HELE Now!
Yesterday Helen Of Troy Ltd (NASDAQ: HELE) reported Q3 EPS that topped estimates by 5 cents. While revenue fell short, shares rose as Wall Street focused on positives. Reports flu season was worse than in previous years also helped support share prices.
Commenting on developments, analyst Lee J. Giordano of Imperial Capital said, "While the external environment for consumer spending continues to be challenging in the U.S. and Europe, Helen of Troy remains well positioned with a diversified product assortment, a strong level of innovation, robust free cash flow generation, and a core competency in acquiring and integrating new brands."
"We believe the healthcare/home environment segment (thermometers, humidifiers, etc.) could potentially benefit from [flu season] in the fiscal fourth quarter (February 2013 end) as the typical flu season stretches from December through March and, most often, peaks in February," added Giordano.
Imperial Capital has an Outperform rating on Helen of Troy (NASDAQ: HELE) with a modified price target of $38.00 (from $35.00).
For an analyst ratings summary and ratings history on Helen of Troy click here. For more ratings news on Helen of Troy click here.
Shares of Helen of Troy closed at $34.43 yesterday, with a 52 week range of $28.02-$35.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Commenting on developments, analyst Lee J. Giordano of Imperial Capital said, "While the external environment for consumer spending continues to be challenging in the U.S. and Europe, Helen of Troy remains well positioned with a diversified product assortment, a strong level of innovation, robust free cash flow generation, and a core competency in acquiring and integrating new brands."
"We believe the healthcare/home environment segment (thermometers, humidifiers, etc.) could potentially benefit from [flu season] in the fiscal fourth quarter (February 2013 end) as the typical flu season stretches from December through March and, most often, peaks in February," added Giordano.
Imperial Capital has an Outperform rating on Helen of Troy (NASDAQ: HELE) with a modified price target of $38.00 (from $35.00).
For an analyst ratings summary and ratings history on Helen of Troy click here. For more ratings news on Helen of Troy click here.
Shares of Helen of Troy closed at $34.43 yesterday, with a 52 week range of $28.02-$35.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Dollar Tree (DLTR) Beats But Looks Stretched - Jefferies
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT Change
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
